<DOC>
	<DOC>NCT00452179</DOC>
	<brief_summary>The purpose of this study is to determine the effects of APD125 in patients with sleep maintenance insomnia.</brief_summary>
	<brief_title>Safety and Efficacy Study of APD125 in Patient With Insomnia</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
	<criteria>Primary insomnia as defined in DSMIVTR, with predominant complaint of impaired sleep maintenance and confirmed by PSG PSQI &gt;/= to 5 Qualifying screening PSG parameters Generally good health History of any sleep disorder, other than primary insomnia (e.g., restless leg syndrome, narcolepsy, sleep apnea, and disorders of REM/NREM sleep) Any clinically significant medical condition, laboratory finding, or ECG finding Pregnant and/or lactating females History of substance abuse within 2 years or positive urine drug screen Positive Hepatitis B/C results or HIV markers ApneaHypopnea Index (AHI) or a Periodic Limb Movement Arousal Index (PLMAI) &gt; 10 as determined by screening PSG History of treatment with an investigational drug within the last month Recent travel involving crossing more than 3 time zones or plans to travel to another time zone (&gt; 3 time zones) during the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>Sleep maintenance</keyword>
	<keyword>Insomnia</keyword>
	<keyword>Sleep Consolidation</keyword>
	<keyword>Sleep</keyword>
	<keyword>Insomnia, primarily sleep maintenance</keyword>
</DOC>